1. Home
  2. AHG vs GNFT Comparison

AHG vs GNFT Comparison

Compare AHG & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHG
  • GNFT
  • Stock Information
  • Founded
  • AHG 2013
  • GNFT 1999
  • Country
  • AHG China
  • GNFT France
  • Employees
  • AHG N/A
  • GNFT N/A
  • Industry
  • AHG Business Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AHG Consumer Discretionary
  • GNFT Health Care
  • Exchange
  • AHG Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • AHG 240.9M
  • GNFT 249.0M
  • IPO Year
  • AHG N/A
  • GNFT 2019
  • Fundamental
  • Price
  • AHG $1.19
  • GNFT $5.52
  • Analyst Decision
  • AHG
  • GNFT Strong Buy
  • Analyst Count
  • AHG 0
  • GNFT 1
  • Target Price
  • AHG N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • AHG 6.8K
  • GNFT 20.1K
  • Earning Date
  • AHG 10-18-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • AHG N/A
  • GNFT N/A
  • EPS Growth
  • AHG N/A
  • GNFT N/A
  • EPS
  • AHG N/A
  • GNFT 0.47
  • Revenue
  • AHG $2,414,338.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • AHG N/A
  • GNFT $155.44
  • Revenue Next Year
  • AHG N/A
  • GNFT N/A
  • P/E Ratio
  • AHG N/A
  • GNFT $11.07
  • Revenue Growth
  • AHG N/A
  • GNFT 175.45
  • 52 Week Low
  • AHG $0.53
  • GNFT $2.89
  • 52 Week High
  • AHG $2.90
  • GNFT $6.05
  • Technical
  • Relative Strength Index (RSI)
  • AHG 59.33
  • GNFT 62.63
  • Support Level
  • AHG $1.04
  • GNFT $5.12
  • Resistance Level
  • AHG $1.20
  • GNFT $6.05
  • Average True Range (ATR)
  • AHG 0.11
  • GNFT 0.28
  • MACD
  • AHG 0.01
  • GNFT 0.03
  • Stochastic Oscillator
  • AHG 96.30
  • GNFT 72.11

About AHG Akso Health Group ADS

Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: